Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pressure BioSciences Inc. PBIO

MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Pending Merger Partner Enters LOI to Acquire Five Leaf Labs

Posted on May 20, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, on Tuesday announced that one of its … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Premium Hand Sanitizer as First Product to be Released Under New Holding Company

Posted on May 14, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that, following its pending merger … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Appointment of Personal Care Industry Leader as CEO to Lead Rebranded Company

Posted on May 7, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO) today announced the appointment of personal care industry leader Jim Morrison to serve as the new CEO of the rebranded public company, with intended corporation name of Availa Bio, upon completion of the merger with Cannaworx, … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Pressure BioSciences Inc. (PBIO) and Cannaworx Inc. Announce Merger Targeting Markets with Massive Cumulative Value

Posted on May 6, 2020 by MissionIR

The merged company will target the international cosmetics market (projected to reach $758 billion by 2025), agricultural technology and products ($729 billion by 2023), the biopharmaceuticals market ($389 billion by 2024) and the hemp-derived CBD market ($23.7 billion by 2023) Cannaworx has … Continue reading →

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reveals Plan to Change Company Name to Availa Bio Upon Completion of Cannaworx, SkinScience Transactions

Posted on May 5, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced its plan to change … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Enters LOI to Acquire SkinScience Labs through Cannaworx

Posted on April 30, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced a letter of intent … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Inks Binding LOI to Acquire Cannaworx, Inc.

Posted on April 29, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that it has signed a binding letter of intent (“LOI”) … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) and RedShiftBio Combine Proprietary Technology to Create Powerful Biotherapeutic Drug Development Platform

Posted on April 16, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, today announced that the combination of PBIO’s patented Pressure Cycling Technology (“PCT”) … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST Demonstration Laboratory Showcases Groundbreaking Technology

Posted on March 20, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the worldwide life sciences and other industries, recently announced the opening of its new Ultra Shear Technology(TM) (“UST”) Demonstration … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Order for Game-Changing UST System from Can B Corp. (CANBD)

Posted on March 12, 2020 by MissionIR

Pressure BioScience (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a purchase order from a new … Continue reading →

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment